phenyl acetate has been researched along with CKD-MBD in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Gotch, F; Kotanko, P; Levin, NW | 1 |
| Bondor, C; Brumboiu, A; Gherman-Caprioara, M; Kacso, I; Moldovan, D; Moldovan, I; Orasan, R; Parvu, L; Patiu, IM; Racasan, S; Rusu, C | 1 |
| Biyik, Z; Demircioglu, S; Ozbek, O; Solak, Y; Turk, S | 1 |
| Neme, G; Peñalba, A; Tirado, S | 1 |
| Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
| Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Barreto, DV; Barreto, FC; Canziani, ME; Carvalho, AB; Draibe, SA; Jorgetti, V; Moysés, RM; Neves, KR | 1 |
| Barzel, US | 1 |
| Franson, KL; Kuk, JM; Lau, AH | 1 |
| Schaefer, K; Umlauf, E; von Herrath, D | 1 |
| Dohi, Y; Kanagawa, S; Yosikawa, Y | 1 |
3 review(s) available for phenyl acetate and CKD-MBD
| Article | Year |
|---|---|
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Topics: Acetates; Algorithms; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Compounds; Calcium Metabolism Disorders; Calcium, Dietary; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Ergocalciferols; Homeostasis; Humans; Intestinal Absorption; Kidney Failure, Chronic; Models, Biological; Phosphorus; Practice Guidelines as Topic; Reference Values; Renal Dialysis; Research Design; Ultrafiltration | 2010 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
3 trial(s) available for phenyl acetate and CKD-MBD
| Article | Year |
|---|---|
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
Topics: Acetates; Adult; Biopsy; Bone Remodeling; Brazil; Calcium Compounds; Chelating Agents; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Polyamines; Practice Guidelines as Topic; Prospective Studies; Reference Values; Renal Dialysis; Sevelamer | 2008 |
Phosphate-binding capacities of calcium and aluminum formulations.
Topics: Acetates; Administration, Oral; Adult; Aluminum Compounds; Calcium Carbonate; Calcium Phosphates; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Monitoring; Female; Gels; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Phosphates; Suspensions; Tablets | 1998 |
7 other study(ies) available for phenyl acetate and CKD-MBD
| Article | Year |
|---|---|
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiography; Renal Dialysis; Risk Factors; Serum Albumin; Sex Factors; Vascular Calcification | 2011 |
Spontaneous bilateral humeral shaft fracture due to severe renal osteodystrophia.
Topics: Acetates; Adenoma; Adult; Calcitriol; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Humeral Fractures; Parathyroid Hormone; Parathyroid Neoplasms; Radiography; Renal Dialysis; Renal Insufficiency; Treatment Outcome | 2011 |
[Vascular and tissue calcifications of hemodialysis patients].
Topics: Acetates; Adult; Aged; Argentina; Calcinosis; Calcium; Calcium Compounds; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Specificity; Phosphorus; Radiography; Renal Dialysis; Vascular Diseases | 2003 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Renal osteodystrophy.
Topics: Acetates; Acetic Acid; Acidosis; Antacids; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Diet; Humans; Phosphates | 1995 |
Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night.
Topics: Acetates; Acetic Acid; Aged; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Circadian Rhythm; Female; Humans; Hypercalcemia; Male; Middle Aged; Phosphates; Renal Dialysis; Risk Factors; Time Factors | 1992 |
[Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure].
Topics: Acetates; Acetic Acid; Allantoin; Aluminum Hydroxide; Bicarbonates; Chronic Kidney Disease-Mineral and Bone Disorder; Citrates; Citric Acid; Drug Combinations; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium Hydroxide; Phosphates | 1991 |